Found 10 matching trials
Comparing the Effects of Sublingual Estradiol Treatment Versus Oral Estradiol With Cyproterone Acetate (CPA) Treatment on The Coagulation System in Transgender Women: A Prospective, Controlled Cohort Study NA The goal of this clinical trial is to learn about the effects of different ...
Show More Location
Tel Aviv Sourasky Medical Center - Institute of Endocrinology, Metabolism and Hypertension
Learn More & Join Trial
Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients N/A Haemophilia is a rare and serious congenital defect of blood coagulation du...
Show More Learn More & Join Trial
TGA (Thrombin Generation Assay) and Prophylaxis in Haemophilia NA Haemophilic arthropathy is one of the major complications of severe haemoph...
Show More Location
Hôpital Pellegrin
Learn More & Join Trial
TFPI Levels in Haemophilia A and B Patients N/A The goal of this study is to measure the TFPI plasma level, a molecule invo...
Show More Learn More & Join Trial
Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis NA Pulmonary embolism, the second leading cause of death in cancer patients, i...
Show More Location
Chu Clermont-Ferrand
Learn More & Join Trial
Thrombin Generation Assay (TGA) as Predictive Test for Haemostatic. Effectiveness of FVIII Concentrates in Haemophiliac A With Inhibitors N/A This is an observational, prospective, longitudinal, multicenter, cohort st...
Show More Location
Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari
Learn More & Join Trial
SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis PHASE3 The purpose of the aPCC-emicizumab safety study is to investigate the hemos...
Show More Location
Children's Healthcare of Atlanta
Learn More & Join Trial
Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections N/A Inflammation and abnormalities in laboratory coagulation tests are insepara...
Show More Location
Medical University Vienna
Learn More & Join Trial
Targeting TFPI With Concizumab to Improve Haemostasis in Glanzmann Thrombasthenia Patients: an in Vitro Study NA Glanzmann thrombasthenia is a rare genetic disorder caused by the absence o...
Show More Location
CHU Bordeaux - Laboratoire Hématologie
Learn More & Join Trial
Study of Erythrocyte Parameters and Hypercoagulability in Sickle Cell Disease (SCD-TGA) N/A Sickle cell disease (SCD) is an inherited haemoglobinopathy disorder caused...
Show More Location
Rouen university Hospital
Learn More & Join Trial